MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202617057608 A) filed by Eli Lilly And Company on May 06, 2026, for Insulin-Fc Fusion Proteins.
Inventors include Beals, John Michael; Day, Jonathan Wesley; and Dickinson, Craig Duane.
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: The present invention relates to fusion proteins comprising an insulin receptor agonist fused to a human IgG2 Fc region, and the use of such fusion proteins in the treatment of diabetes. The fusion protein of the present invention has an extended time action profile and is useful for providing basal glucose control for an extended period of time.
Disclaimer: Curated by HT Syndication.
